Haleon boosts US sales by targeting consumers on weight-loss drugs

Advil-maker Haleon is boosting its US sales by targeting consumers who use weight-loss drugs, according to Reuters and CNBC. The consumer-health company is positioning its products toward the growing GLP-1 user base.

Detected & updated continuously · Source: Nebula